Bangladesh Approves China’s Sinovac Covid-19 Vaccine for Emergency Use

Bangladesh has approved the Covid-19 vaccine CoronaVac developed by China’s Sinovac Life Sciences Company Limited for emergency use amid a supply crunch.

The Directorate General of Drug Administration (DGDA) announced the approval on Sunday.

The DGDA gave the go ahead on June 3, after M/s Incepta Vaccine Ltd applied for its approval for emergency use.

In a press release today, the DGDA said that CoronaVac is the fifth vaccine to be given the Emergency Use Authorization (EUA).

The World Health Organization approved the emergency use of Sinovac vaccine on June 1.

The Sinovac jab is already in use in 22 territories around the world.

Earlier on April 29, Bangladesh approved the Covid-19 vaccine developed by China’s Sinopharm for emergency use, after clearing Russia’s Sputnik V vaccine.

On May 7, the WHO granted emergency approval for Sinopharm, the first vaccine produced in China.